Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A07321 | 32540177 | J Hepatol | Blocking integrin α4β7-mediated CD4 T cell recruitment to the intestine and liver protects mice from western diet-induced non-alcoholic steatohepatitis. | 2020 | Details |
| A07322 | 32538722 | Curr Protein Pept Sci | Gut Barrier Proteins Mediate Liver Regulation by the Effects of Serotonin on the Non-Alcoholic Fatty Liver Disease. | 2020 | Details |
| A07323 | 32537840 | Hepatol Res | Modelling the economic and clinical burden of non-alcoholic steatohepatitis in East Asia: Data from Hong Kong. | 2020 | Details |
| A07325 | 32536770 | World J Gastroenterol | Metabolic inflammation as an instigator of fibrosis during non-alcoholic fatty liver disease. | 2020 | Details |
| A07326 | 32536582 | Clin Nutr | Impact of short-term overfeeding of saturated or unsaturated fat or sugars on the gut microbiota in relation to liver fat in obese and overweight adults. | 2020 | Details |
| A07327 | 32535780 | Dig Dis Sci | Development of an Algorithm to Identify Cases of Nonalcoholic Steatohepatitis Cirrhosis in the Electronic Health Record. | 2020 | Details |
| A07328 | 32535386 | Biomed Pharmacother | HCBP6 deficiency exacerbates glucose and lipid metabolism disorders in non-alcoholic fatty liver mice. | 2020 | Details |
| A07329 | 32534989 | Chem Biol Interact | Roles of peroxisome proliferator-activated receptor α in the pathogenesis of ethanol-induced liver disease. | 2020 | Details |
| A07330 | 32534588 | Cardiovasc Diabetol | Non-alcoholic steatohepatitis and progression of carotid atherosclerosis in patients with type 2 diabetes: a Korean cohort study. | 2020 | Details |
| A07331 | 32534575 | Cardiovasc Diabetol | Cardiovascular morbidity, diabetes and cancer risk among children and adolescents with severe obesity. | 2020 | Details |
| A07332 | 32533953 | Ann Hepatol | Non-alcoholic fatty liver disease and microRNAs expression, how it affects the development and progression of the disease. | 2020 | Details |
| A07333 | 32533233 | Pathologe | [Histopathological diagnosis and differential diagnosis of nonalcoholic fatty liver disease]. | 2020 | Details |
| A07334 | 32532204 | BMC Gastroenterol | Efficacy of serum miRNA test as a non-invasive method to diagnose nonalcoholic steatohepatitis: a systematic review and meta-analysis. | 2020 | Details |
| A07335 | 32532003 | Int J Mol Sci | Physiological Disturbance in Fatty Liver Energy Metabolism Converges on IGFBP2 Abundance and Regulation in Mice and Men. | 2020 | Details |
| A07336 | 32531941 | Nutrients | Poor Adherence to Mediterranean Diet and Serum Lipopolysaccharide are Associated with Oxidative Stress in Patients with Non-Alcoholic Fatty Liver Disease. | 2020 | Details |
| A07337 | 32531862 | Oral Dis | Bromelain reduces the non-alcoholic fatty liver disease and periodontal damages caused by ligature-induced periodontitis. | 2020 | Details |
| A07338 | 32531442 | Ann Diagn Pathol | Automated quantification and architectural pattern detection of hepatic fibrosis in NAFLD. | 2020 | Details |
| A07339 | 32531415 | J Hepatol | Non-alcoholic fatty liver disease in pregnancy is associated with adverse maternal and perinatal outcomes. | 2020 | Details |
| A07340 | 32531370 | Int J Biol Macromol | The protective effects of walnut green husk polysaccharide on liver injury, vascular endothelial dysfunction and disorder of gut microbiota in high fructose-induced mice. | 2020 | Details |
| A07341 | 32531342 | Clin Gastroenterol Hepatol | Nonalcoholic Steatohepatitis Is the Most Rapidly Increasing Indication for Liver Transplantation in the United States. | 2020 | Details |
| A07342 | 32531295 | Metabolism | Changing trends of liver transplantation and mortality from non-alcoholic fatty liver disease. | 2020 | Details |
| A07344 | 32530991 | J Gastrointestin Liver Dis | Identification of Patients with Advanced Fibrosis Due to Nonalcoholic Fatty Liver Disease: Considerations for Best Practice. | 2020 | Details |
| A07345 | 32530988 | J Gastrointestin Liver Dis | The Association between Periodontitis and Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis. | 2020 | Details |
| A07347 | 32529712 | Clin Physiol Funct Imaging | FDG PET/CT of the non-malignant liver in an increasingly obese world population. | 2020 | Details |
| A07348 | 32529694 | Mol Nutr Food Res | Resveratrol Alleviates Endoplasmic Reticulum Stress-Associated Hepatic Steatosis and Injury in Mice Challenged with Tunicamycin. | 2020 | Details |
| A07349 | 32529412 | Diabetologia | Exercise and metabolic health: beyond skeletal muscle. | 2020 | Details |
| A07350 | 32529354 | Obes Surg | Correlation between Obstructive Sleep Apnea and Non-Alcoholic Fatty Liver Disease before and after Metabolic Bariatric Surgery. | 2020 | Details |
| A07351 | 32528557 | Diabetol Metab Syndr | Association of [1H]-MRS quantified liver fat content with glucose metabolism status. | 2020 | Details |
| A07352 | 32528465 | Front Immunol | Perforin Acts as an Immune Regulator to Prevent the Progression of NAFLD. | 2020 | Details |
| A07353 | 32527258 | Lipids Health Dis | Lipoprotein A, combined with alanine aminotransferase and aspartate aminotransferase, contributes to predicting the occurrence of NASH: a cross-sectional study. | 2020 | Details |
| A07354 | 32527116 | Chin Clin Oncol | Hepatocellular carcinoma, novel therapies on the horizon. | 2020 | Details |
| A07355 | 32526850 | Molecules | The Potential Therapeutic Value of Medicinal Plants in the Management of Metabolic Disorders. | 2020 | Details |
| A07356 | 32526845 | Int J Mol Sci | N-Acetylcysteine Reduced Ischemia and Reperfusion Damage Associated with Steatohepatitis in Mice. | 2020 | Details |
| A07357 | 32526796 | Mol Nutr Food Res | Dietary Fiber from Oat and Rye Brans Ameliorate Western Diet-Induced Body Weight Gain and Hepatic Inflammation by the Modulation of Short-Chain Fatty Acids, Bile Acids, and Tryptophan Metabolism. | 2020 | Details |
| A07358 | 32526788 | Semin Liver Dis | The NLRP3 Inflammasome in Alcoholic and Nonalcoholic Steatohepatitis. | 2020 | Details |
| A07359 | 32526787 | Semin Liver Dis | Nonalcoholic Steatohepatitis Promoting Kinases. | 2020 | Details |
| A07360 | 32526784 | Semin Liver Dis | Noninvasive Tests in the Assessment of NASH and NAFLD Fibrosis: Now and Into the Future. | 2020 | Details |
| A07361 | 32526482 | Cell Mol Gastroenterol Hepatol | Acetyl-CoA Carboxylase Inhibition Improves Multiple Dimensions of NASH Pathogenesis in Model Systems. | 2020 | Details |
| A07362 | 32526241 | Eur J Pharmacol | Berbamine induced AMPK activation regulates mTOR/SREBP-1c axis and Nrf2/ARE pathway to allay lipid accumulation and oxidative stress in steatotic HepG2 cells. | 2020 | Details |
| A07363 | 32525261 | J Ultrasound Med | Novel Method for Ultrasound-Derived Fat Fraction Using an Integrated Phantom. | 2020 | Details |
| A07364 | 32525256 | IUBMB Life | APOC3rs2854116, PNPLA3rs738409, and TM6SF2rs58542926 polymorphisms might influence predisposition of NAFLD: A meta-analysis. | 2020 | Details |
| A07365 | 32524859 | Expert Opin Drug Discov | How effective are nonalcoholic fatty liver disease models for drug discovery? | 2020 | Details |
| A07366 | 32524395 | Chin J Integr Med | Intestinal Microecology: An Important Target for Chinese Medicine Treatment of Non-alcoholic Fatty Liver Disease. | 2020 | Details |
| A07367 | 32524150 | Naunyn Schmiedebergs Arch Pharmacol | Berberine attenuates non-alcoholic steatohepatitis by regulating chemerin/CMKLR1 signalling pathway and Treg/Th17 ratio. | 2020 | Details |
| A07368 | 32524096 | Hawaii J Health Soc Welf | Nonalcoholic Fatty Liver Disease: An Important Consideration for Primary Care Providers in Hawai'i. | 2020 | Details |
| A07369 | 32523869 | Curr Hepatol Rep | NAFLD in women: Unique pathways, biomarkers and therapeutic opportunities. | 2019 | Details |
| A07370 | 32523627 | Therap Adv Gastroenterol | Plasma eicosanoids as noninvasive biomarkers of liver fibrosis in patients with nonalcoholic steatohepatitis. | 2020 | Details |
| A07371 | 32523319 | World J Gastroenterol | Association between non-alcoholic fatty liver disease and obstructive sleep apnea. | 2020 | Details |
| A07372 | 32523311 | World J Gastroenterol | Role of γδT cells in liver diseases and its relationship with intestinal microbiota. | 2020 | Details |
| A07373 | 32523101 | Sci Rep | Prediction of advanced fibrosis in non-alcoholic fatty liver disease using gut microbiota-based approaches compared with simple non-invasive tools. | 2020 | Details |
| A07374 | 32522731 | BMJ Open Diabetes Res Care | Regional difference in the susceptibility of non-alcoholic fatty liver disease in China. | 2020 | Details |
| A07375 | 32522273 | Trials | Traditional Chinese medicine Lingguizhugan decoction treating non-alcoholic fatty liver disease with spleen-yang deficiency pattern: Study protocol for a multicenter randomized controlled trial. | 2020 | Details |
| A07376 | 32522147 | Environ Health Prev Med | Influence of increased physical activity without body weight loss on hepatic inflammation in patients with nonalcoholic fatty liver disease. | 2020 | Details |
| A07377 | 32521615 | Cancers (Basel) | Hepatocellular Carcinoma Emergence in Diabetic Mice with Non-Alcoholic Steatohepatitis Depends on Diet and Is Delayed in Liver Exhibiting an Active Immune Response. | 2020 | Details |
| A07378 | 32521450 | Biomed Pharmacother | Chinese herbal medicine mixture 919 syrup alleviates nonalcoholic fatty liver disease in rats by inhibiting the NF-κB pathway. | 2020 | Details |
| A07379 | 32520458 | Rev Med Suisse | [NASH: a less known but severe complication of diabetes]. | 2020 | Details |
| A07380 | 32520409 | Br J Pharmacol | Sirtuin 3-mediated deacetylation of acyl-CoA synthetase family member 3 by protocatechuic acid attenuates non-alcoholic fatty liver disease. | 2020 | Details |
| A07381 | 32519629 | J Dev Orig Health Dis | Hepatic lipid metabolism in adult rats using early weaning models: sex-related differences. | 2020 | Details |
| A07382 | 32519009 | Curr Diab Rep | Purine Metabolite Signatures and Type 2 Diabetes: Innocent Bystanders or Actionable Items? | 2020 | Details |
| A07383 | 32518675 | Clin Diabetes Endocrinol | Nonalcoholic fatty liver disease and type 2 diabetes: where do Diabetologists stand? | 2020 | Details |
| A07384 | 32518428 | Clin Biochem Rev | Serum Marker Panels for Predicting Liver Fibrosis - An Update. | 2020 | Details |
| A07385 | 32518275 | Sci Rep | The PPAR α/γ Agonist Saroglitazar Improves Insulin Resistance and Steatohepatitis in a Diet Induced Animal Model of Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A07386 | 32518245 | Sci Rep | Self-reported snoring is associated with nonalcoholic fatty liver disease. | 2020 | Details |
| A07387 | 32518225 | Nutr Diabetes | Consumption of a high energy density diet triggers microbiota dysbiosis, hepatic lipidosis, and microglia activation in the nucleus of the solitary tract in rats. | 2020 | Details |
| A07388 | 32518095 | CMAJ Open | Burden of nonalcoholic fatty liver disease in Canada, 2019-2030: a modelling study. | 2020 | Details |
| A07389 | 32517710 | BMC Gastroenterol | Value of routine test for identifying colorectal cancer from patients with nonalcoholic fatty liver disease. | 2020 | Details |
| A07390 | 32516937 | Int J Mol Sci | Elastography Techniques for the Assessment of Liver Fibrosis in Non-Alcoholic Fatty Liver Disease. | 2020 | Details |
| A07391 | 32516202 | Am J Gastroenterol | Deciding Among Noninvasive Tools for Predicting Varices Needing Treatment in Chronic Liver Disease: An Analysis of Asian Cohort. | 2020 | Details |
| A07392 | 32516028 | Am J Physiol Endocrinol Metab | NOD2 in hepatocytes engages a liver-gut axis to protect against steatosis, fibrosis, and gut dysbiosis during fatty liver disease in mice. | 2020 | Details |
| A07393 | 32515888 | J Occup Health | Effects of obesity, metabolic syndrome, and non-alcoholic or alcoholic elevated liver enzymes on incidence of diabetes following lifestyle intervention: A subanalysis of the J-DOIT1. | 2020 | Details |
| A07394 | 32515880 | Liver Int | Mechanisms for increased risk of diabetes in chronic liver diseases. | 2020 | Details |
| A07395 | 32515534 | Hepatol Res | Validation of albumin, bilirubin, and platelet criteria for avoiding screening endoscopy in patients with advanced fibrosis. | 2020 | Details |
| A07396 | 32514669 | Adv Ther | Troponin Levels Relate to CRP Concentrations in Patients With NAFLD on Maintenance Haemodialysis: A Retrospective Study. | 2020 | Details |
| A07397 | 32514497 | JHEP Rep | Combined alcoholic and non-alcoholic steatohepatitis. | 2020 | Details |
| A07398 | 32514465 | JGH Open | No association between binge eating disorder and severity of non-alcoholic fatty liver disease in severely obese patients. | 2020 | Details |
| A07399 | 32514460 | JGH Open | Discordant pathological diagnosis of non-alcoholic fatty liver disease: A prospective multicenter study. | 2019 | Details |
| A07400 | 32514458 | JGH Open | Liver disease referrals to an urban, hospital-based hepatology outpatient clinic over the past 25 years. | 2019 | Details |
| A07401 | 32514450 | JGH Open | Sodium-glucose cotransporter 2 inhibition does not reduce hepatic steatosis in overweight, insulin-resistant patients without type 2 diabetes. | 2019 | Details |
| A07402 | 32514444 | JGH Open | Thyroid-stimulating hormone is an independent risk factor of non-alcoholic fatty liver disease. | 2019 | Details |
| A07403 | 32514433 | JGH Open | Epidemiological differences of common liver conditions between Asia and the West. | 2019 | Details |
| A07405 | 32514025 | Nutr Diabetes | Association between famine exposure in early life with insulin resistance and beta cell dysfunction in adulthood. | 2020 | Details |
| A07406 | 32513303 | Stem Cell Res Ther | Mesenchymal stem cell-derived exosomes exert ameliorative effects in type 2 diabetes by improving hepatic glucose and lipid metabolism via enhancing autophagy. | 2020 | Details |
| A07407 | 32512752 | Nutrients | The Effect of Three Mediterranean Diets on Remnant Cholesterol and Non-Alcoholic Fatty Liver Disease: A Secondary Analysis. | 2020 | Details |
| A07408 | 32512581 | PLoS One | Polysaccharides isolated from Cordyceps Sinensis contribute to the progression of NASH by modifying the gut microbiota in mice fed a high-fat diet. | 2020 | Details |
| A07409 | 32512191 | Biochim Biophys Acta Mol Basis Dis | Extracellular vesicles derived from fat-laden hepatocytes undergoing chemical hypoxia promote a pro-fibrotic phenotype in hepatic stellate cells. | 2020 | Details |
| A07410 | 32512072 | Toxicol Appl Pharmacol | Diosmin ameliorates inflammation, insulin resistance, and fibrosis in an experimental model of non-alcoholic steatohepatitis in rats. | 2020 | Details |
| A07411 | 32510837 | Liver Int | Relationship between hepatic and systemic angiopoietin-like 3, hepatic Vitamin D receptor expression and NAFLD in obesity. | 2020 | Details |
| A07414 | 32509277 | F1000Res | Recent advances in understanding and managing pediatric nonalcoholic fatty liver disease. | 2020 | Details |
| A07415 | 32508918 | Int J Endocrinol | Neck Circumference is an Effective Supplement for Nonalcoholic Fatty Liver Disease Screening in a Community-Based Population. | 2020 | Details |
| A07416 | 32508312 | Eur J Endocrinol | Non-alcoholic fatty liver disease: a multidisciplinary approach towards a cardiometabolic liver disease. | 2020 | Details |
| A07417 | 32508268 | Toxicol Pathol | Utilization of a Deep Learning Algorithm for Microscope-Based Fatty Vacuole Quantification in a Fatty Liver Model in Mice. | 2020 | Details |
| A07418 | 32508064 | J Korean Med Sci | Nonalcoholic Fatty Liver Disease Is Associated with Benign Prostate Hyperplasia. | 2020 | Details |
| A07419 | 32507551 | Ann Hepatol | Prevalence of NAFLD in Guatemala following exposure to a protein-energy nutrition intervention in early life. | 2020 | Details |
| A07420 | 32507446 | Complement Ther Med | A pilot study of the effect of curcumin on epigenetic changes and DNA damage among patients with non-alcoholic fatty liver disease: A randomized, double-blind, placebo-controlled, clinical trial. | 2020 | Details |
| A07421 | 32507439 | Complement Ther Med | Effects of garlic powder supplementation on insulin resistance, oxidative stress, and body composition in patients with non-alcoholic fatty liver disease: A randomized controlled clinical trial. | 2020 | Details |
| A07422 | 32506830 | J Diabetes Investig | Glucagon regulates lipolysis and fatty acid oxidation through inositol triphosphate receptor 1 in the liver. | 2020 | Details |
| A07423 | 32506513 | J Gastroenterol Hepatol | Use of metabolic syndrome severity to assess treatment with vitamin E and pioglitazone for non-alcoholic steatohepatitis. | 2020 | Details |
| A07424 | 32505776 | Clin Chim Acta | Intestinal microbiota-farnesoid X receptor axis in metabolic diseases. | 2020 | Details |
| A07425 | 32505733 | Clin Res Hepatol Gastroenterol | PPARγ gene Pro12Ala variants reduce the risk of obese individuals to non-alcoholic fatty liver: A study in Uygur Chinese population residing in Northwestern China. | 2020 | Details |
| A07426 | 32504921 | Biomed Pharmacother | The influence of probiotics on bile acids in diseases and aging. | 2020 | Details |